In a large-animal model study, researchers have found that heart attack recovery is aided by the injection of heart muscle cell spheroids derived from human-induced pluripotent stem cells (hiPSCs), that overexpress cyclin D2 and are knocked out for human leukocyte antigen classes I and II.
Leave A Comment